A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip

JAMA

Volumn 275, Issue 11, 1996, Pages 858-865

  Chang, Rowland W ^b   Pellissier, James M ^b   Hazen, Gordon B ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; COXITIS; FEMALE; HUMAN; INFECTION RATE; LIFE EXPECTANCY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; TOTAL HIP PROSTHESIS; TREATMENT FAILURE;

EID: 0029870824     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.11.858     Document Type: Article

References (70)

1. Harris WH, Sledge CB. Total hip and total knee replacement. N Engl J Med. 1990;323:725-731.
2. NIH Consensus Development Panel on Total Hip Replacement. Total hip replacement. JAMA. 1995;273:1950-1956.
3. Friedman B, Elixhauser A. Increased use of an expensive, elective procedure: total hip replacements in the 1980s. Med Care. 1993;31:581-596.
4. Liang MH, Cullen KE, Larson MG, et al. Cost-effectiveness of total joint-arthroplasty in osteoarthritis. Arthritis Rheum. 1986;29:937-943.
5. Laupacis A, Bourne R, Rorabeck C, et al. Costs of elective total hip arthroplasty during the first year. J Arthroplasty. 1994;9:481-487.
6. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-662.
7. Hazen GB. Stochastic trees: a new technique for temporal medical decision modeling. Med Decis Making. 1992;12:163-178.
8. Hazen GB. Factored stochastic trees: a tool for solving complex temporal medical decision making problems. Med Decis Making. 1993;13:227-236.
9. Cox DR. A use of complex probabilities in the theory of stochastic processes. Proc Camb Phil Soc 1955;51:313-319.
10. PeDissier JM, Hazen GB. Coxian mortality factors for stochastic tree modelling. Med Decis Making. 1994;14:439. Abstract.
11. Mortality, part A. In: Vital Statistics of the United States. Hyattsville, Md: US Dept of Health and Human Services; 1993:2:12.
12. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures; treatment and end-result stage using a new method of result evaluation. J Bone Joint Surg Am. 1969;51A:737-755.
13. Kavanagh BF, Fitzgerald RH Jr. Clinical and roentgenographic assessment of total hip arthroplasty: a new hip score. Clin Orthop. 1985;193:133-140.
14. Kavanagh BF, Dewitz MA, Ilstrup DM, Stauffer RN, Coventry MB. Charnley total hip arthroplasty with cement: fifteen-year results. J Bone Joint Surg Am. 1989;71A:1496-1503.
15. Kavanagh BF, Fitzgerald RH Jr. Multiple revisions for failed total hip arthroplasty not associated with infection. J Bone Joint Surg Am. 1987; 69A:1144-1149.
16. Sanzen L, Carlsson AS, Josefsson G, Lindberg LT. Revision operations on infected total hip arthroplasties. Clin Orthop Rel Res. 1988;229:165-172.
17. White RH, MeCurdy SA, Marder RA. Early morbidity after total hip replacement: rheumatoid arthritis versus osteoarthritis. J Gen Intern Med. 1990;5:304-309.
18. Coventry MB, Beckenbaugh RD, Nolan DR, Ilstrup DM. 2012 total hip arthroplasties: a study of postoperative causes and early complications. J Bone Joint Surg Am. 1974;56A:273-284.
19. Orthopedic Knowledge Update. Volume IV. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 1993.
20. Booth RE, Balderston RA, Rothman RH. Total Hip Arthroplasty. Philadelphia, Pa: WB Saunders Co; 1988.
21. Beckenbaugh R, Ilstrup DM. Total hip arthroplasty: a review of three hundred thirty-three cases with long follow-up. J Bone Joint Surg Am. 1978; 60A:306-313.
22. Eftekhar NS, Tzitzikalakis GI. Failures and reoperations following low-friction arthroplasty of the hip. Clin Orthop. 1986;211:65-78.
23. Herberts P, Ahnfelt L, Malchau M, Stromberg C, Andersson GBJ. Multicenter clinical trials and their value in assessing total joint arthroplasty. Clin Orthop. 1989;249:48-55.
24. Schulte KR, Callaghan JJ, Kelley SS, Johnston RC. The outcome of Charnley total hip arthroplasty with cement after a minimum twenty-year followup. J Bone Joint Surg Am. 1993;75A:961-975.
25. Schutzer SF, Harris WH. Deep-wound infection after total hip replacement under contemporary aseptic conditions. J Bone Joint Surg Am. 1988;70A:724-727.
26. Hunter GA, Welsh EP, Cameron HU, Bailey WH. The results of revision total hip arthroplasty. J Bone Joint Surg Br. 1979;61B:419-421.
27. Jones JM. Revisional total hip replacement for failed Ring arthroplasty. J Bone Joint Surg Am. 1979;61A:1029-1034.
28. Hoogland T, Razzano CD, Marks KE, Wilde AH. Revision of Mueller total hip arthroplasties. Clin Orthop. 1981;161:180-185.
29. Anderson MA, Murray WR. Revision surgery for failed total hip arthroplasty. Orthop Trans. 1981; 5:75.
30. Cameron HU, Fedorkow DM. The early results of the Bateman single assemble total hip used as a revision prosthesis. Acta Orthop Belg. 1981;47:49-53.
31. Pellici PM, Wilson PD Jr, Sledge CB, Salvati EA, Ranawat CS, Poss R. Revision total hip arthroplasty. Clin Orthop. 1982;170:34-41.
32. Gustilo EB, Pasternak HS. Revision total hip arthroplasty with titanium ingrowth prosthesis and bone grafting for failed cemented femoral component loosening. Clin Orthop. 1988;235:111-119.
33. Retpen JB, Varmarken J, Steen Jensen J. Survivorship analysis of failure pattern after revision total hip arthroplasty. J Arthroplasty. 1989;4:311-317.
34. Marti EK, Schu̇ller HM, Besselaar PP. Vanfrank Haasnoot EL. Results of revision of hip arthroplasty with cement: a five to fourteen-year follow-up. J Bone Joint Surg Am. 1990;72A:346-354.
35. Estok DM, Harris WH. Long-term results of cemented femoral revision surgery using secondgeneration techniques: an average 11.7-year followup evaluation. Clin Orthop. 1994;299:190-202.
36. Wroblewski BM. Results of the Charnley low-friction arthroplasty. Clin Orthop. 1986;211:30-35.
37. Older J. Low-friction arthroplasty of the hip: a ten to twelve year follow-up study. Clin Orthop. 1986;211:36-42.
38. Dall DM, Grobbelaar CJ, Learmonth ID, et al. Charnley low-friction arthroplasty of the hip: long-term results in South Africa. Clin Orthop. 1986; 211:85-90.
39. Jinnah EH, Chir B, Amstutz HC, Tooke SM, Dorey F, Dalseth T. The UCLA Charnley experience: a long-term follow-up using survival analysis. Clin Orthop. 1986;211:164-172.
40. McCoy TH, Salvati EA, Ranawat CS, Wilson PD. A fifteen-year follow-up study of one hundred Charnley low-friction arthroplasties. Orthop Clin North Am. 1988;19:467-476.
41. Fowler JL, Gie GA, Lee AJ, et al. Experience with the Exeter total hip replacement since 1970. Orthop Clin North Am. 1988;19:477-489.
42. Russotu GM, Coventry MB, Stauffer RN. Cemented total hip arthroplasty with contemporary techniques. Clin Orthop. 1988;235:141-147.
43. Collis DK. Long term results of an individual surgeon. Orthop Clin North Am 1988;19:541-550.
44. Schurman DJ, Bloch DA, Segal MR, Tanner CM. Conventional cemented total hip arthroplasty: assessment of clinical factors associated with revision for mechanical failure. Clin Orthop. 1989;240: 172-180.
45. Mulroy RD, Harris WH. The effect of improved cementing techniques on component loosening in total hip replacement: an eleven year radiographic review. J Bone Joint Surg Br. 1990;72B:757-760.
46. Gustilo RB, Kyle RF. Revision of femoral component loosening with titanium ingrowth prosthesis and bone grafting. In: Welch RB, ed. Proceedings of the 12th Annual Meeting of the Hip Society. St Louis, Mo: CV Mosby: 1984:342-346.
47. Amstutz HC, Ma SM, Jinnah RH, Mai L. Revision of aseptic loose total hip arthroplasties. Clin Orthop. 1982;170:21-33.
48. Broughton NS, Rushton H. Revision hip arthroplasty. Acta Orthop Scand. 1982;53:923-928.
49. Esses S, Hastings D, Schatzker J. Revision of total hip arthroplasty. Can J Surg. 1983;26:345-347.
50. Reigstad A, Hetland KR. Rearthroplasty after conventional total hip prosthesis and double cup prosthesis. Arch Orthop Traumatic Surg. 1984;103: 152-155.
51. Pellici PM, Wilson PD Jr, Sledge CB, et al, Long-term results of revision total hip replacement: a follow-up report. J Bone Joint Surg Am. 1985; 67A:513-516.
52. Kavanagh BF, Ilstrup DM, Fitzgerald RH Jr. Revision total hip arthroplasty. J Bone Joint Surg Am. 1985;67A:517-526.
53. James ETR, Hunter GA, Cameron HU. Total hip revision arthroplasty: does sepsis influence the results? Clin Orthop. 1982;170:88-94.
54. Danielsson LG. Incidence and prognosis of cox-arthrosis. Acta Orthop Scand. 1964;66:9-87.
55. Pellissier JM, Hazen GB. Implementation of continuous risk utility assessment: the total hip replacement decision. Socio-Economic Plann Sci 1994;28:251-276.
56. Laupacis A, Bourne R, Rorabeck C, et al. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am. 1993; 75A:1619-1626.
57. Katz JN, Phillips CB, Fossel AH, Liang MH. Stability and responsiveness of utility measures. Med Care. 1994;32:183-188.
58. Barber TC, Healy WL. The hospital cost of total hip arthroplasty. J Bone Joint Surg Am. 1993; 75A:321-325.
59. Economic Indicators. Washington, DC: US Government Printing Office; December 1994:23.
60. Background Facts on Aging Services. American Association of Homes and Services for the Aging: April 1994.
61. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation. 1952;66(suppl III):56-65.
62. Garner TI, Dardis E. Cost-effectiveness analysis of end stage renal disease treatments. Med Care. 1987;20:25-34.
63. Edelson JT, Weinstein MC, Tosteson AN, Williams L, Lee TH. Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263:407-413.
64. Mushlin AI, Fintor L. Is screening for breast cancer cost-effective? Cancer. 1992;69:1957-1962.
65. Kinosian BP, Eisenberg JM. Cutting into cholesterol: cost-effective alternatives for treating hypercholesterolema. JAMA 1988;259:2249-2254.
66. Eddy DM, Hasselblad V, McGivney W, Hendee W. The value of mammography screening in women under age 50 years. JAMA. 1988;259:1512-1519.
67. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med. 1995;332:719-724.
68. Schulman KA, Lynn LA, Glick HA, Eisenberg JM. Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection. Ann Intern Med. 1991;114:798-802.
69. Kaplan RM, Bush JV, Berry CC. Health status: types of validity and the index of well-being. Health Serv Res. 1976;4:478-507.
70. Whittle J, Steinberg EP, Anderson GF, Herbert R, Hochberg MC. Mortality after elective total hip arthroplasty in elderly Americans: age, gender, and indication for surgery predict survival. Clin Orthop. 1993;205:119-126.